Graft Versus Host Disease Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Graft Versus Host Disease
  • Hematologic Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-11-23
Nov 23, 2021
N
Recruiting
  • Graft Versus Host Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2021-11-17
    Nov 17, 2021
    H
    Not yet recruiting
    • Graft Versus Host Disease
    • (no location specified)
    2021-11-05
    Nov 5, 2021
    U
    Not yet recruiting
    • Skin Microbiome
    • +2 more
    • Skin swabs
    • +2 more
    • Basel, Switzerland
      Department of Dermatology; University Hospital Basel
    2021-11-03
    Nov 3, 2021
    A
    Completed
    • Graft Versus Host Disease
    • Lewes, Delaware
    • +15 more
    2021-10-05
    Oct 5, 2021
    N
    Recruiting
    • Graft Versus Host Disease
    • +2 more
    • Ruxolitinib 1.5% cream
    • vehicle cream
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2021-10-14
    Oct 14, 2021
    L
    Completed
    • Graft Versus Host Disease
    • Allogeneic Hematopoietic Cell Transplant Recipient
    • Regulatory T Cells
    • Palo Alto, California
      Stanford University, School of Medicine
    2021-09-20
    Sep 20, 2021
    D
    Active, not recruiting
    • Cutaneous T Cell Lymphoma
    • Graft Versus Host Disease
      • Lebanon, New Hampshire
        Dartmouth-Hitchcock Medical Center
      2021-08-31
      Aug 31, 2021
      F
      Completed
      • Hematopoietic Stem Cell Transplantation
      • Graft Versus Host Disease
      • Optimization cohort
      • Control cohort
      • Sevilla, Seville, Spain
      • +4 more
      2021-08-24
      Aug 24, 2021
      E
      Suspended
      • Graft Versus Host Disease
      • donor regulatory T lymphocytes
      • laboratory biomarker analysis
      • Stanford, California
        Stanford University Hospitals and Clinics
      2021-08-18
      Aug 18, 2021
      R
      Terminated
      • Graft Versus Host Disease
      • Hematopoietic Cell Transplantation Recipient
      • Dietary Intervention
      • Laboratory Biomarker Analysis
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      2021-08-20
      Aug 20, 2021
      E
      Recruiting
      • Graft Versus Host Disease
      • Birmingham, Alabama
      • +6 more
      2021-08-05
      Aug 5, 2021
      M
      Active, not recruiting
      • Sickle Cell Disease
      • Graft Versus Host Disease
      • Washington, District of Columbia
      • +6 more
      2021-08-04
      Aug 4, 2021
      R
      Recruiting
      • Acute Myeloid Leukemia in Remission
      • +12 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +7 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      2021-08-02
      Aug 2, 2021
      H
      Completed
      • Graft Versus Host Disease
      • GVHD
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      2021-07-19
      Jul 19, 2021
      C
      Recruiting
      • Graft Versus Host Disease
      • Stanford, California
        Stanford Hospital
      2021-07-16
      Jul 16, 2021
      H
      Active, not recruiting
      • Graft Versus Host Disease
      • Cultured Treg cells
      • Tampa, Florida
        H Lee Moffitt Cancer Center
      2021-07-12
      Jul 12, 2021
      W
      Active, not recruiting
      • Graft Versus Host Disease
      • Hematopoietic/Lymphoid Cancer
      • fludarabine phosphate
      • +5 more
      • Winston-Salem, North Carolina
        Comprehensive Cancer Center of Wake Forest University
      2021-07-06
      Jul 6, 2021
      M
      Completed
      • Graft Versus Host Disease
      • +2 more
      • filgrastim
      • +8 more
      • New York, New York
        Memorial Sloan-Kettering Cancer Center
      2021-06-21
      Jun 21, 2021
      C
      Active, not recruiting
      • Chronic Myeloproliferative Disorders
      • +7 more
      • (no location specified)
      2021-06-10
      Jun 10, 2021
      R
      Completed
      • Graft Versus Host Disease
      • Lactobacillus rhamnosus GG
      • laboratory biomarker analysis was not performed because of no differences in the clinical outcomes
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      2021-04-23
      Apr 23, 2021
      Z
      Recruiting
      • Graft Versus Host Disease
      • Ruxolitinib+Calcineurin +Methotrexate
      • Calcineurin +Methotrexate+Mycophenolate mofetil
      • Hangzhou, Zhejiang, China
        The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
      2021-04-08
      Apr 8, 2021
      S
      Recruiting
      • Graft Versus Host Disease
      • Ramat Gan, Israel
        Chaim Sheba Medical Center
      2021-03-16
      Mar 16, 2021